News

LCF Georgia Welcomes Mariángela Corales to Its Board

LCF Georgia Strengthens Leadership Team with the Appointment of Mariángela Corales to Its Board of DirectorsATLANTA, GA / ACCESSWIRE /…

2 years ago

Biotech Commercialization Leader, Amy Mahery, to Join CNS Pharmaceuticals Board of Directors

Highly accomplished biopharmaceutical industry executive with successful track record in the commercialization and launch of drugs in varied therapeutic areas…

2 years ago

Just in Time GCP Announces New Leadership for Consulting & Partnership Programs

Ashley Bates Transitions to Sr. Director Consulting & Partnerships at Just in Time GCPPHILADELPHIA, PA / ACCESSWIRE / January 18,…

2 years ago

Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China

Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics MarketsLAVAL, QC / ACCESSWIRE / January 18, 2024…

2 years ago

Bone Health Technologies Announces FDA Clearance of OsteoboostTM, the First Prescription Medical Device to Treat Low Bone Density

Osteoboost is the first and only non-pharmacological prescription treatment to demonstrate reduced loss of bone strength in postmenopausal womenRepresents the…

2 years ago

Genflow Biosciences PLC Announces Two Non-Dilutive Research Grant Awards

Secures Two Research Grants from Belgium's New Technological Innovation PartnershipLONDON, UK / ACCESSWIRE / January 18, 2024 / The Company…

2 years ago

Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer

Carolyn's strategic vision and experience will be integral to securing and creating top talent to advance Envision's priorities.FAIRFIELD, CT /…

2 years ago

Cannabix Quantifies Marijuana Breath Samples from Maryland Green Lab – Results Analyzed at North Louisiana Criminalistics Laboratory

Cannabix Technologies Inc. Fig. 1 Cannabix at North Louisiana Crime Lab Cannabix Technologies Inc. Fig. 2 Cannabix MSBS at North…

2 years ago

Elevar Therapeutics To Present Two Posters From Phase 3 CARES-310 Study at 2024 ASCO Gastrointestinal Cancers Symposium

A post hoc analysis found the efficacy of camrelizumab plus rivoceranib was superior to sorafenib regardless of baseline liver function…

2 years ago

Surrozen Provides Corporate Update on Clinical Programs

Announces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcohol-Associated Hepatitis SZN-043- Completed enrollment for the…

2 years ago